> and there is potential for a pharmaceutical company to patent and profit from it, then you can generally rest assured that it will be scheduled to require a doctor's prescription
Guess what? Belgian company did this, it is sold under brand name Nootropil in many countries. The patent is already expired, so there is probably little benefit in bringing it to the US market.